Project profile — Gavi, the Vaccine Alliance - Institutional Support 2021-2025

• Africa, regional (69.00%)
• America, regional (1.00%)
• Asia, regional (30.00%)

• Basic Health: Infectious disease control (12250) (84.00%)
• Noncommunicable diseases: Other prevention and treatment of NCDs (12350) (5.00%)
• Family planning:
Family planning (13030) (6.00%)
STD control including HIV/AIDS (13040) (5.00%)

• Gender equality (significant objective)
• Environmental sustainability (cross-cutting) (significant objective)
• Children's issues (principal objective)
• Youth Issues (principal objective)

This grant represents Canada’s long-term institutional support to Gavi, the Vaccine Alliance. Gavi uses these funds, along with other donors’ funding, to achieve its mandate. Gavi’s long-term mission is saving lives and protecting people’s health by increasing equitable and sustainable vaccine use. This project supports Gavi's four strategic goals for the current period (2021 to 2025). Project activities include: introducing and scaling up vaccines against infectious disease, including human papillomavirus and malaria, through procurement and delivery support; (2) strengthening health systems to increase immunization equity, including dedicated support to extend immunization services to under-immunized and zero-dose children; (3) improving the sustainability of national immunizations programs; and (4) ensuring healthy markets for vaccines and related products.

The expected outcomes for this project include: (1) 300 million additional children immunized; (2) 82 new vaccine programs introduced; (3) 7 to 8 million additional lives saved; and (4) US$ 80 to 100 billion in economic benefits produced.

Results achieved as of December 2023 include: (1) the project vaccinated 205 million children; (2) introduced 42 new vaccine programs; (3) saved 3.7 million additional lives; and (4) produced US$52 billion in economic benefits.

• Proactive disclosure
• Related activities: GAVI HPV Vaccine Program